Related Experiment Video
Updated: Feb 13, 2026
06:47
Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
10.2K
Targeting IgE Antibodies by Immunoadsorption in Atopic Dermatitis
Michael Kasperkiewicz1, Enno Schmidt1,2, Ralf J Ludwig1,2
1Department of Dermatology, University of Lübeck, Lübeck, Germany.
Frontiers in Immunology
|March 10, 2018
Summary
Immunoadsorption (IA) is being explored as a novel treatment for atopic dermatitis (AD) by targeting elevated, potentially autoreactive, immunoglobulin E (IgE) levels. This approach shows promise for severe AD cases unresponsive to conventional therapies.
Area of Science:
- Dermatology
- Immunology
- Allergy Research
Background:
- Atopic dermatitis (AD) is characterized by high total serum IgE.
- A subset of AD patients exhibits autoreactive IgE.
- Immunoadsorption (IA) is effective in other autoantibody-mediated diseases.
Purpose of the Study:
- To review the emerging use of IA for severe atopic dermatitis.
- To discuss IA as a treatment targeting autoreactive IgE in AD.
- To explore the role of autoreactive IgE in AD pathogenesis and treatment.
Main Methods:
- Literature review of IA application in AD.
- Analysis of current knowledge on IA for severe AD.
- Discussion of autoreactive IgE as a therapeutic target.
Main Results:
- IA has been proposed for severe AD with high IgE.
- IA has a precedent in treating autoantibody-mediated conditions.
- The role of autoreactive IgE in AD and its response to IA requires further investigation.
Conclusions:
- IA represents a novel therapeutic avenue for severe atopic dermatitis.
- Targeting autoreactive IgE with IA may benefit specific AD patient populations.
- Further research is needed to fully elucidate IA's efficacy and the role of autoreactive IgE in AD.
Related Concept Videos
01:10Antibody Structure
65.8K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.8K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.9K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.9K
01:26Antibody Actions
3.0K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
3.0K
01:25Antibody Structure and Classes
9.4K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
9.4K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:26Targets for Drug Action: Overview
10.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.5K